Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Presentation ESC 2017

Bivalirudin vs Heparin Monotherapy in Myocardial Infarction:The VALIDATE-SWEDEHEART Trial

Presenter: David Erlinge

August 27, 2017

Hypothermia #2: Critical Appraisal of Hypothermia Outcomes for Infarct Size Reduction: Integrated Analysis of All Clinical Studies

Presentation TCT 2014

Hypothermia #2: Critical Appraisal of Hypothermia Outcomes for Infarct Size Reduction: Integrated Analysis of All Clinical Studies

Presenter: Francisco Fdez-Aviles, Abhiram Prasad, David Erlinge

September 16, 2014

CHILL-MI: Rapid Endovascular Catheter Core Cooling Combined with Cold Saline as an Adjunct to PCI for Acute MI

Presentation

CHILL-MI: Rapid Endovascular Catheter Core Cooling Combined with Cold Saline as an Adjunct to PCI for Acute MI

Presenter: David Erlinge

February 04, 2014

Hypothermia To Reduce Infarct Size 1: From Predicate Studies to CHILL-MI

Presentation TCT 2013

Hypothermia To Reduce Infarct Size 1: From Predicate Studies to CHILL-MI

Presenter: David Erlinge

October 31, 2013

CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI

Presentation TCT 2013

CHILL-MI: A Prospective, Randomized Trial of Therapeutic Hypothermia in Patients with Acute Myocardial Infarction Undergoing Primary PCI

Presenter: David Erlinge

October 30, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.